March 27, 2025 US prosecutors probe tip about timing of Pfizer's COVID vaccine, WSJ reports Federal prosecutors in Manhattan are probing a claim by GSK that Pfizer delayed announcing its COVID ...

The British pharma claimed that the Pfizer vaccine infringed on four of its patents related to the antigen technology used in its shot. At that time, the emerging RSV vaccine market was billed as ...

(Reuters) -British pharmaceutical giant GlaxoSmithKline and rival Pfizer have agreed to end a lawsuit that alleged Pfizer's respiratory syncytial virus (RSV) vaccine Abrysvo violated GSK's patent ...

Pfizer slashed its production targets for its COVID-19 vaccine because of a lack of raw materials for its supply chain, according to press reports. The big pharma has said in recent weeks that it ...

Current flu vaccines generally offer only around 40% to 60% protective efficacy, but can limit the severity of infections. According to Pfizer and BioNTech, this is the first time that an mRNA ...

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET. 1037 ET – Big Pharma could mitigate a 20% drug tariff by ...

Five years ago, volunteers rolled up their sleeves in the first clinical trial of a vaccine against COVID-19, as the new pandemic surged around them. By a year later, 66 million American adults had ...

Pfizer isn't a great pick for growth investors, although its growth prospects are better than some might think. The stock is a good fit for value investors, though, with its low forward earnings ...

The probe is reportedly backed by U.S. presidential candidate Robert F. Kennedy Jr., who has frequently challenged the safety of vaccines despite ... know closer to the time but I'm keeping ...

As always, we will point out this is a fine time to enjoy the great outdoors ... Institutional Shareholder Services has recommended Pfizer investors reject a proposal on executive compensation ...